Literature DB >> 2872271

Free and conjugated 3,4-dihydroxyphenylacetic acid and homovanillic acid in brain dopaminergic areas at basal state and after pipotiazine activation.

E Tavitian, L Peyrin, Y Dalmaz, R Favre, M De Haut, J M Cottet-Emard.   

Abstract

We have determined free and conjugated 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in discrete brain areas of rats. Conjugated HVA or DOPAC accounted for 22-38% of total acids in striatum, mesolimbic tissue or prefrontal cortex. Activation of dopamine (DA) metabolism by a single injection of pipotiazine palmitic ester (PPZ), a long-lasting neuroleptic, increased free acid levels (DOPAC and HVA) at either dose and conjugate levels after 32 or 50 mg/kg. 48 hours after PPZ-32 mg/kg, the observed increases of conjugates could exceed in some cases those of corresponding free acids. About half of total DOPAC and HVA were conjugated in hypothalamus, PPZ moderately increased free DOPAC (at 32 mg/kg) but did not elevate significantly the conjugated form. It is concluded that sulfation is an important pathway for DOPAC and HVA metabolism in brain and that the determination of both free and conjugated DOPAC or/and HVA may shed additional lights on regional DA metabolism and the effect of drugs thereon.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872271     DOI: 10.1007/bf01249087

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  37 in total

1.  Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.

Authors:  L Julou; B Scatton; J Glowinski
Journal:  Adv Biochem Psychopharmacol       Date:  1977

2.  Rapid post mortem changes in 3,4-dihydroxyphenylacetic acid (DOPAC), a dopamine metabolite, in rat striatum.

Authors:  P Moleman; J Bruinvels; B H Westerink
Journal:  J Neurochem       Date:  1977-07       Impact factor: 5.372

3.  Long-term effects of unilateral 6-hydroxydopamine destruction of the dopaminergic nigrostriatal pathway on the urinary excretion of catecholamines (dopamine, norepinephrine, epinephrine) and their metabolites in the rat.

Authors:  L Peyrin; J M Cottet-Emard; F Javoy; Y Agid; A Herbet; J Glowinski
Journal:  Brain Res       Date:  1978-03-31       Impact factor: 3.252

4.  Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite.

Authors:  S M Schanberg; J J Schildkraut; G R Breese; I J Kopin
Journal:  Biochem Pharmacol       Date:  1968-02       Impact factor: 5.858

5.  Differential changes in DOPAC levels in the hippocampal formation, septum and striatum of the rat induced by acute and repeated neuroleptic treatment.

Authors:  B Scatton
Journal:  Eur J Pharmacol       Date:  1981-05-22       Impact factor: 4.432

6.  Effects of amphetamine on catecholamine levels and turnover in discrete hypothalamic areas.

Authors:  S F Leibowitz; M Jhanwar-Uniyal; B E Levin
Journal:  Brain Res       Date:  1983-05-05       Impact factor: 3.252

7.  Determination of picomole amounts of dopamine, noradrenaline, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindolacetic acid in nervous tissue after one-step purification on Sephadex G-10, using high-performance liquid chromatography with a novel type of electrochemical detection.

Authors:  B H Westerink; T B Mulder
Journal:  J Neurochem       Date:  1981-04       Impact factor: 5.372

8.  Simultaneous determination of the formation rate of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in various rat brain areas.

Authors:  B H Westerink; S J Spaan
Journal:  Brain Res       Date:  1982-12-09       Impact factor: 3.252

9.  Determination of conjugated monoamine metabolites in brain tissue.

Authors:  C G Swahn; F A Wiesel
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

10.  Presence of conjugated catecholamines in rat brain: a new method of analysis of catecholamine sulfates.

Authors:  N T Buu; J Duhaime; C Savard; L Truong; O Kuchel
Journal:  J Neurochem       Date:  1981-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.